Dr. Michaela Rancea is currently the Director of Value, Access & Pricing Oncology at Pfizer, demonstrating a strong background in health technology assessment and market access. Previously, Dr. Rancea held key roles at Seagen as Market Access Lead for Germany and at Takeda as Manager of Health Technology Assessment. Their academic contributions include guest lectureships at the German Cochrane Centre and Hochschule Fresenius, focusing on evidence-based medicine and critical appraisal of clinical trials. Dr. Rancea earned a Dr. rer. medic. in Evidence-based Medicine from Universität zu Köln and has extensive experience in methodological expertise, clinical guidelines development, and project management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices